1
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating hepatitis C virus. Idenix Pharmaceuticals, Sherry M Knowles Esq, King & Spalding, July 5, 2005: US06914054 (102 worldwide citation)

A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


2
Paulo LaColla, Jean Pierre Sommadossi: Methods and compositions for treating flaviviruses and pestiviruses. Idenix Pharmaceuticals, Sherry M Knowles Esq, King & Spalding, November 2, 2004: US06812219 (89 worldwide citation)

A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


3
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating flaviviruses and pestiviruses. Idenix Pharmaceuticals, Universita Degli Studi di Cagliari, Sherry M Knowles Esq, King & Spalding, September 12, 2006: US07105493 (81 worldwide citation)

A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


4
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating flaviviruses and pestiviruses. Idenix Pharmaceuticals, Universita Degli Studi Di Cagliari, Sherry M Knowles Esq, King & Spalding, December 12, 2006: US07148206 (76 worldwide citation)

A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


5
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating flaviviruses and pestiviruses. Idenix Pharmaceuticals, Universita Degli Studi Di Cagliari, Sherry M Knowles Esq, King & Spalding, January 16, 2007: US07163929 (73 worldwide citation)

A method and composition for treating a host infected with flavivirus or pestivirus comprising administering an effective flavivirus or pestivirus treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


6
Richard Storer, Gilles Gosselin, Jean Pierre Sommadossi, Paola LaColla: infections, Modified 2′ and 3′-nucleoside prodrugs for treating. Idenix Pharmaceuticals, University of Cagliari, Centre National de la Recherche Scientifique, L Universite Montfellier II, Jones Day, October 27, 2009: US07608600 (69 worldwide citation)

2′ and/or 3′ prodrugs of 1′, 2′, 3′ or 4′-branched nucleosides, and their pharmaceutically acceptable salts and derivatives are described. These prodrugs are useful in the prevention and treatment of Flaviviridae infections, including HCV infection, and other related conditions. Compounds and compos ...


7
Martin L Bryant, Jean Pierre Sommadossi: Methods of treating hepatitis delta virus infection with &bgr;-L-2′-deoxy-nucleosides. Idenix Pharmaceuticals, Sherry M Knowles Esq, King & Spalding, September 7, 2004: US06787526 (67 worldwide citation)

A method and composition for treating a host infected with hepatitis D comprising administering an effective hepatitis D treatment amount of a described 2′-deoxy-&bgr;-L-erythro-pentofuranonucleoside or a pharmaceutically acceptable salt or prodrug thereof.


8
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating hepatitis C virus. Idenix Pharmaceuticals, Universita Degli Studi Di Cagliari, Jones Day, October 27, 2009: US07608597 (57 worldwide citation)

A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


9
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating hepatitis C virus. Idenix Pharmaceuticals, Universita Degli Studi di Cagliari, Sherry M Knowles Esq, King & Spalding, January 30, 2007: US07169766 (56 worldwide citation)

A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.


10
Jean Pierre Sommadossi, Paulo LaColla: Methods and compositions for treating hepatitis C virus. Idenix Pharmaceuticals, Universita Degli Studi Di Cagliari, Sherry M Knowles Esq, King & Spalding, January 2, 2007: US07157441 (55 worldwide citation)

A method and composition for treating a host infected with hepatitis C comprising administering an effective hepatitis C treatment amount of a described 1′, 2′ or 3′-modified nucleoside or a pharmaceutically acceptable salt or prodrug thereof, is provided.